Dr. Kabil Chunprapaph

D.M.D | Dentist



  
  1304 Macom Dr, Ste 4, Naperville
  Illinois, 60564-9300

  630-585-5005    630-585-5727 Maps & Directions
Dr. Kabil Chunprapaph is a Naperville, Illinois based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 1304 Macom Dr, Ste 4, Naperville. Patients can reach him at 630-585-5005.
Dr. Kabil Chunprapaph is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. Kabil Chunprapaph speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. Kabil Chunprapaph
Specialization: Dentist
Gender:Male
Credentials: D.M.D
Accepts Medicare Assignment:May Accept
Practice Address:1304 Macom Dr, Ste 4, Naperville,
Illinois, 60564-9300
Phone:630-585-5005
Fax:630-585-5727
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 2163714593
Enrollment ID: I20160706000481
NPI Number: 1134132947
NPI Enumeration Date: 14 Aug, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 2293 Wildhorse Dr,
Aurora, Illinois
Zip: 60503-4673
Patients can reach Dr. Kabil Chunprapaph at 1304 Macom Dr, Ste 4, Naperville, Illinois or can call to book an appointment on 630-585-5005. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.

Comments/ Reviews: